SCHEMBL19606990

SCHEMBL19606990

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc(-c4cc(-c5ccc6oc7ccccc7c6c5)c5sc6ccccc6c5c4)cc3)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.38
▸ PLA2G2A P14555 3/20 0.36
▸ PLA2G4A P47712 3/20 0.36
▸ TNKS O95271 2/20 0.36
▸ TNKS2 Q9H2K2 1/20 0.36
▸ PRKDC P78527 1/20 0.34
▸ MAPT P10636 3/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ LIMK1 P53667 1/20 0.34
▸ HSP90AA1 P07900 1/20 0.32
▸ HSP90AB1 P08238 1/20 0.32
▸ PLA2G10 O15496 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29312619 0.99 ALOX5 (0.38) ALOX5PLA2G2APLA2G4ATNKSTNKS2
SCHEMBL29312677 0.98 ALOX5 (0.38) ALOX5PLA2G2APLA2G4ATNKSTNKS2
SCHEMBL19607127 0.97 PLA2G2A (0.38) ALOX5PLA2G2APLA2G4ATNKSTNKS2
SCHEMBL19607007 0.94 ALOX5 (0.38) ALOX5PLA2G2APLA2G4ATNKSTNKS2
SCHEMBL29312616 0.93 ALOX5 (0.37) ALOX5PLA2G2APLA2G4ATNKSTNKS2
SCHEMBL24393839 0.93 ALOX5 (0.43) ALOX5PLA2G2APLA2G4ATNKSTNKS2
SCHEMBL29312673 0.90 ALOX5 (0.39) ALOX5PLA2G2APLA2G4ATNKSTNKS2
SCHEMBL29328456 0.89 ALOX5 (0.36) ALOX5PRKDCLIMK1
SCHEMBL24171066 0.89 PLA2G2A (0.42) ALOX5PLA2G2APLA2G4ATNKSTNKS2
SCHEMBL12282971 0.88 ALOX5 (0.45) ALOX5PLA2G2APLA2G4ATNKSTNKS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12041848-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2024-07-16 — — US disclosed
US-12041848-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2024-07-16 — — US disclosed
WO-2017196081-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME SK CHEMICALS CO., LTD. (KR) 2017-11-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12041848-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 ALOX5 1089/4885PLA2G2A 4191/4885PLA2G4A 4195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback